Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Machine scores (provisional)
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
- Teacher spread
- 0.242 · how far apart the two teachers sit on this one work
- Validation status
score_only:v0-immature-baseline· verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it
Abstract
Clinical and translational research has played a major role in advancing our understanding of pulmonary hypertension (PH), including pulmonary arterial hypertension and other forms of PH with severe vascular remodelling ( e.g. chronic thromboembolic PH and pulmonary veno-occlusive disease). However, PH remains an incurable condition with a high mortality rate, underscoring the need for a better transfer of novel scientific knowledge into healthcare interventions. Herein, we review recent findings in pathology (with the questioning of the strict morphological categorisation of various forms of PH into pre- or post-capillary involvement of pulmonary vessels) and cellular mechanisms contributing to the onset and progression of pulmonary vascular remodelling associated with various forms of PH. We also discuss ways to improve management and to support and optimise drug development in this research field.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- European Respiratory Journal
- Topic
- Pulmonary Hypertension Research and Treatments
- Field
- Medicine
- Canadian institutions
- Université LavalInstitut universitaire de cardiologie et de pneumologie de Québec
- Funders
- National Heart, Lung, and Blood InstituteStanford UniversityJanssen Research and DevelopmentUnited Therapeutics CorporationPfizer
- Keywords
- Pulmonary hypertensionMedicineChronic thromboembolic pulmonary hypertensionIntensive care medicineVascular remodelling in the embryoPulmonary vasculatureTranslational researchPulmonary pathologyDiseasePsychological interventionClinical PracticePathologyCardiologyLungInternal medicinePhysical therapy
- Has abstract in OpenAlex
- yes